Back
Prelude Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
64
PRLD
Prelude Therapeutics, Inc.
Last Price:
$3.47
Seasonality Move:
-11.72%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PRLD is experiencing slight selling pressure.
Prelude Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.26 | Buy |
| 20-day SMA: | 3.29 | Buy |
| 50-day SMA: | 2.73 | Buy |
| 200-day SMA: | 1.73 | Buy |
| 8-day EMA: | 3.31 | Buy |
| 20-day EMA: | 3.19 | Buy |
| 50-day EMA: | 2.86 | Buy |
| 200-day EMA: | 2.06 | Buy |
Prelude Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.15 | Buy |
| Relative Strength Index (14 RSI): | 59.5 | Buy |
| Chaikin Money Flow: | -2710 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.92 - 3.46) | Buy |
| Bollinger Bands (100): | (1.67 - 2.99) | Buy |
Prelude Therapeutics, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Prelude Therapeutics, Inc. Stock
Is Prelude Therapeutics, Inc. Stock a Buy?
-
Prelude Therapeutics, Inc. share price is 3.46 while PRLD 8-day simple moving average is 3.26, which is a Buy signal.
-
The stock price of PRLD is 3.46 while Prelude Therapeutics, Inc. 20-day SMA is 3.29, which makes it a Buy.
-
Prelude Therapeutics, Inc. 50-day simple moving average is 2.73 while PRLD share price is 3.46, making it a Buy technically.
-
PRLD stock price is 3.46 and Prelude Therapeutics, Inc. 200-day simple moving average is 1.73, creating a Buy signal.
PRLD Technical Analysis vs Fundamental Analysis
Buy
64
Prelude Therapeutics, Inc. (PRLD)
is a Buy
Is Prelude Therapeutics, Inc. a Buy or a Sell?
-
Prelude Therapeutics, Inc. stock is rated a BuyThe current Prelude Therapeutics, Inc. [PRLD] share price is $3.46. The Score for PRLD is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
Prelude Therapeutics, Inc. Stock Info
Market Cap:
219.3M
Price in USD:
3.46
Share Volume:
105.7K
Prelude Therapeutics, Inc. 52-Week Range
52-Week High:
4.22
52-Week Low:
0.61
Buy
64
Prelude Therapeutics, Inc. (PRLD)
is a Buy
Prelude Therapeutics, Inc. Share Price Forecast
-
What is the Prelude Therapeutics, Inc. stock price today?The Prelude Therapeutics, Inc. stock price is 3.46 USD today.
-
Will PRLD stock go up or go down?Prelude Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Prelude Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Prelude Therapeutics, Inc. is not overvalued.
Is Prelude Therapeutics, Inc. Stock a Buy?
-
Prelude Therapeutics, Inc. share price is 3.46 while PRLD 8-day exponential moving average is 3.31, which is a Buy signal.
-
The stock price of PRLD is 3.46 while Prelude Therapeutics, Inc. 20-day EMA is 3.19, which makes it a Buy.
-
Prelude Therapeutics, Inc. 50-day exponential moving average is 2.86 while PRLD share price is 3.46, making it a Buy technically.
-
PRLD stock price is 3.46 and Prelude Therapeutics, Inc. 200-day simple moving average is 2.06, creating a Buy signal.
Fundamental Analysis of Prelude Therapeutics, Inc.
Is Prelude Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.16 per share, and a decrease next year of $0.00 per share.
Technical Analysis of Prelude Therapeutics, Inc.
Should I short Prelude Therapeutics, Inc. stock?
-
PRLD Moving Average Covergence Divergence (MACD) indicator is 0.15, suggesting Prelude Therapeutics, Inc. is a Buy
-
Prelude Therapeutics, Inc. Relative Strength Index (RSI) is 59.5, which suggest Prelude Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Prelude Therapeutics, Inc. is (2.92 - 3.46), which suggest Prelude Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Prelude Therapeutics, Inc. is (1.67 - 2.99), which suggest Prelude Therapeutics, Inc. is a Buy
* Prelude Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.